Melanoma
Latest News
More than 97K new cutaneous melanoma diagnoses expected in 2023
More than 1.3 million people in the United States live with cutaneous melanoma, and the overall 5-year survival is 93.7%.
Latest News
Dermoscopy, other modalities for improving melanoma diagnoses reviewed
The learning curve for dermoscopy is steep, he added, and whether the technique should be considered a first-line tool or as a supplement to other...
From the Journals
Spectrum of dermatologic adverse events associated with amivantamab use
It is important for dermatologists and oncologists to be aware of the severe and atypical dAEs associated with this novel therapy....
Latest News
Dermatopathologist reflects on the early history of melanoma
Melanoma was often regarded as a fungal infection in the early 1800s.
Latest News
How should PRAME be used to evaluate melanocytic lesions?
One potential pitfall is that sun-damaged melanocytes may express PRAME.
Diminutio
Oncologists may be too quick to refer patients to palliative care
Integrating palliative care into routine cancer care need not always require a specialty palliative care nurse.
Latest News
Regular vitamin D supplements may lower melanoma risk
In the study, there were significantly fewer individuals in the regular vitamin D use group with a past of present history of melanoma compared...
Latest News
Study spotlights clinicopathologic features, survival outcomes of pediatric melanoma
The median Breslow thickness was 2.7 mm in children and 1.0 mm in adolescents.
Feature
Cancer clinics begin to accommodate patients demanding new cancer detection tests
Sales teams are making a big push for multicancer early detection tests.
Latest News
Adverse events linked to better survival with ICIs in melanoma
“We feel these findings will help clinicians in discussions with patients and in clinical decision-making after adverse events develop,” one of...
Latest News
Melanoma mortality rates fell in 2010s as new therapies took hold
Immunotherapy and targeted therapy appear to be paying dividends, new study finds.